These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33417506)

  • 1. Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy.
    Absolom K; Warrington L; Hudson E; Hewison J; Morris C; Holch P; Carter R; Gibson A; Holmes M; Clayton B; Rogers Z; McParland L; Conner M; Glidewell L; Woroncow B; Dawkins B; Dickinson S; Hulme C; Brown J; Velikova G
    J Clin Oncol; 2021 Mar; 39(7):734-747. PubMed ID: 33417506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment.
    Absolom K; Holch P; Warrington L; Samy F; Hulme C; Hewison J; Morris C; Bamforth L; Conner M; Brown J; Velikova G;
    BMC Cancer; 2017 May; 17(1):318. PubMed ID: 28482877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Online Symptom Monitoring During Pelvic Radiation Therapy: Randomized Pilot Trial of the eRAPID Intervention.
    Holch P; Absolom KL; Henry AM; Walker K; Gibson A; Hudson E; Rogers Z; Holmes M; Peacock R; Pini S; Gilbert A; Davidson S; Routledge J; Murphy A; Franks K; Hulme C; Hewison J; Morris C; McParland L; Brown J; Velikova G
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):664-676. PubMed ID: 36241128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy.
    Holch P; Pini S; Henry AM; Davidson S; Routledge J; Brown J; Absolom K; Gilbert A; Franks K; Hulme C; Morris C; Velikova G;
    Pilot Feasibility Stud; 2018; 4():110. PubMed ID: 29992040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Online tool for monitoring adverse events in patients with cancer during treatment (eRAPID): field testing in a clinical setting.
    Warrington L; Absolom K; Holch P; Gibson A; Clayton B; Velikova G
    BMJ Open; 2019 Feb; 9(1):e025185. PubMed ID: 30782751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy.
    Dawkins B; Absolom K; Hewison J; Warrington L; Hudson E; Holch P; Carter R; Gibson A; Holmes M; Rogers Z; Dickinson S; Morris C; Woroncow B; Brown J; Hulme C; Velikova G
    JCO Oncol Pract; 2024 Apr; 20(4):581-590. PubMed ID: 38266205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engaging Patients and Clinicians in Online Reporting of Adverse Effects During Chemotherapy for Cancer: The eRAPID System (Electronic Patient Self-Reporting of Adverse Events: Patient Information and aDvice).
    Absolom K; Gibson A; Velikova G
    Med Care; 2019 May; 57 Suppl 5 Suppl 1():S59-S65. PubMed ID: 30985598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery.
    Richards HS; Blazeby JM; Portal A; Harding R; Reed T; Lander T; Chalmers KA; Carter R; Singhal R; Absolom K; Velikova G; Avery KNL
    BMC Cancer; 2020 Jun; 20(1):543. PubMed ID: 32522163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment.
    Holch P; Warrington L; Bamforth LCA; Keding A; Ziegler LE; Absolom K; Hector C; Harley C; Johnson O; Hall G; Morris C; Velikova G
    Ann Oncol; 2017 Sep; 28(9):2305-2311. PubMed ID: 28911065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Gr├╝nwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
    Basch E; Schrag D; Henson S; Jansen J; Ginos B; Stover AM; Carr P; Spears PA; Jonsson M; Deal AM; Bennett AV; Thanarajasingam G; Rogak LJ; Reeve BB; Snyder C; Bruner D; Cella D; Kottschade LA; Perlmutter J; Geoghegan C; Samuel-Ryals CA; Given B; Mazza GL; Miller R; Strasser JF; Zylla DM; Weiss A; Blinder VS; Dueck AC
    JAMA; 2022 Jun; 327(24):2413-2422. PubMed ID: 35661856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT.
    Mooney KH; Beck SL; Wong B; Dunson W; Wujcik D; Whisenant M; Donaldson G
    Cancer Med; 2017 Mar; 6(3):537-546. PubMed ID: 28135050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer.
    Maguire R; Fox PA; McCann L; Miaskowski C; Kotronoulas G; Miller M; Furlong E; Ream E; Armes J; Patiraki E; Gaiger A; Berg GV; Flowerday A; Donnan P; McCrone P; Apostolidis K; Harris J; Katsaragakis S; Buick AR; Kearney N
    BMJ Open; 2017 Jun; 7(5):e015016. PubMed ID: 28592577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06).
    Strasser F; Blum D; von Moos R; Cathomas R; Ribi K; Aebi S; Betticher D; Hayoz S; Klingbiel D; Brauchli P; Haefner M; Mauri S; Kaasa S; Koeberle D;
    Ann Oncol; 2016 Feb; 27(2):324-32. PubMed ID: 26646758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol of the TIRED study: a randomised controlled trial comparing either graded exercise therapy for severe fatigue or cognitive behaviour therapy with usual care in patients with incurable cancer.
    Poort H; Verhagen CA; Peters ME; Goedendorp MM; Donders AR; Hopman MT; Nijhuis-van der Sanden MW; Berends T; Bleijenberg G; Knoop H
    BMC Cancer; 2017 Jan; 17(1):81. PubMed ID: 28129746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.
    Basch E; Deal AM; Kris MG; Scher HI; Hudis CA; Sabbatini P; Rogak L; Bennett AV; Dueck AC; Atkinson TM; Chou JF; Dulko D; Sit L; Barz A; Novotny P; Fruscione M; Sloan JA; Schrag D
    J Clin Oncol; 2016 Feb; 34(6):557-65. PubMed ID: 26644527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot randomized trial of an electronic symptom monitoring intervention for hospitalized patients with cancer.
    Nipp RD; El-Jawahri A; Ruddy M; Fuh C; Temel B; D'Arpino SM; Cashavelly BJ; Jackson VA; Ryan DP; Hochberg EP; Greer JA; Temel JS
    Ann Oncol; 2019 Feb; 30(2):274-280. PubMed ID: 30395144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART).
    Maguire R; McCann L; Kotronoulas G; Kearney N; Ream E; Armes J; Patiraki E; Furlong E; Fox P; Gaiger A; McCrone P; Berg G; Miaskowski C; Cardone A; Orr D; Flowerday A; Katsaragakis S; Darley A; Lubowitzki S; Harris J; Skene S; Miller M; Moore M; Lewis L; DeSouza N; Donnan PT
    BMJ; 2021 Jul; 374():n1647. PubMed ID: 34289996
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.